Bristol-Myers Squibb Company

NYSE: BMY
$57.68
-$0.32 (-0.6%)
Closing Price on December 27, 2024

BMY Articles

Major Pharma Short Interest Takes a Small Step Back
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
Chris Lange
Published:
Last Updated:

Short Sellers Increase Bets in Major Pharma
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Chris Lange
Published:
Last Updated:

Short Sellers Increase Bets in Major Pharma
The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Chris Lange
Published:
Last Updated:

Short Sellers Become More Selective on Major Pharma
The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Chris Lange
Published:
Last Updated:

Major Pharma Short Sellers Increase Bets
The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks short interest was up.
Chris Lange
Published:
Last Updated:

Major Pharma Short Interest Takes Another Giant Leap Forward
The short interest data have been released for the December 15 settlement date, and for most of the selected pharmaceutical stocks short interest was up.
Chris Lange
Published:
Last Updated:

Short Interest in Major Pharma Takes a Giant Leap
The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was up.
Chris Lange
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: athenahealth, AT&T, Cepheid, Chevron, Dollar General, Mobileye and Many More
Wednesday's top analyst upgrades, downgrades and initiations include Athenhealth, AT&T, Cepheid, Chevron, Dollar General and Mobileye.
Jon C. Ogg
Published:
Last Updated:

Short Sellers Continue to Decrease Bets in Major Pharma
The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical stocks, short interest was down.
Chris Lange
Published:
Last Updated:

Short Sellers Have Mixed Views on Major Pharma
The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Chris Lange
Published:

Short Sellers Become More Selective on Major Pharma
The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Chris Lange
Published:

5 Big FDA Decisions Expected in October
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of October and added some color.
Chris Lange
Published:

Short Sellers Boost Positions in Major Pharma
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
Chris Lange
Published:

Short Sellers Become More Selective in Major Pharma
The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short interest is mixed.
Chris Lange
Published:

Short Sellers Have Mixed Feelings on Major Pharma
The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
Chris Lange
Published: